Topics will include:
The Role of Biomarkers in the Assessment of CVD Risk
Behavior Change Theories and Strategies to Promote Medication Adherence and Exercise
Home Blood Pressure Monitoring in the Management of Hypertension
The American Heart Association’s High Blood Pressure Research Conference is a two-and-one-half day scientific program with more than 450 presentations focusing on recent advances in hypertension research. The conference will provide an educational program for physicians and research investigators that will enhance their knowledge advance their skills and apprise them of the latest developments in research pertaining to hypertension and its relationship to stroke, cardiac disease, kidney function/renal diseases, obesity and genetics.
Orlando Regional Medical Center campus , Orlando , Florida
Description:
This is a one-day, six-hour AMA category I CME and AANP CEU course exploring the role of apolipoproteins, cystatin-C, NT-proBNP, genetic markers and testing for autosomal dominant hyperlipidemia in stratifying and treating cardiovascular risk. The course will be held at the Orlando Regional Medical Center campus in the M.D. Anderson cancerCenter classrooms LP1 & 2. CME accreditation is provided by Orlando Regional Healthcare Systems. CEU accreditation is provided by the Preventative Cardiovascular Nursing Association. The course is also endorsed by the National Lipid Association. A continental breakfast and box lunch will be provided.
Please call 407-671-8598 to register.
Registration is $50 on or before October 1 and $75 after October 1.
PCNA’s Annual Symposium continues to be the source for cutting-edge information, best practices, and national guidelines in cardiovascular risk reduction and disease management.
Jointly hosted by the Southwest and Pacific Regional Chapters, join us at this 2-day conference where we will present you with the latest lipid science and show you how to apply it to your clinical practice.
This conference is the principal venue for presenting population-based research that drives the world’s contemporary approach to CVD prevention. This conference encourages and promotes the development, advancement and exchange of new information related to prevention and treatment of heart disease and stroke.
The programs focus on the presentation of new research and are organized around oral and poster abstract presentations with specially integrated translational science lectures and debates on current issues in preventive cardiology.
